How long before Wegovy kicks in — and what to expect while you wait

What the STEP 1 trial data actually shows about timing

The STEP 1 trial is the clearest window we have into how semaglutide 2.4mg performs over time. Across 68 weeks, participants without diabetes lost an average of around 15% of their starting body weight, a result the trial authors, writing in the New England Journal of Medicine, described as substantially greater than anything seen with previous weight-management medicines at the time. But the trial's week-by-week data tells an equally important story: weight loss was not uniform. The steepest reductions came in the middle months, roughly weeks 16 to 36, once participants had reached the full 2.4mg maintenance dose and their bodies had adjusted to it.

In practical terms, that means the first month on Wegovy is largely about tolerability, not transformation. Your prescriber titrates the dose upward gradually (starting at 0.25mg, stepping through 0.5mg, 1.0mg and 1.7mg before reaching 2.4mg) specifically to reduce the nausea and digestive discomfort that can accompany the early stages. Think of those first weeks as the groundwork. The weight loss follows. For those using the newer 7.2mg dose, approved by the MHRA in April 2026, the same principle applies: the same gradual start, a longer escalation, and results that continue to build.

The six-month mark matters clinically. NICE guidance on semaglutide recommends reviewing whether to continue if body weight loss is less than 5% after six months at the maintenance dose. That threshold is a useful anchor for anyone wondering whether the medicine is working for them.

What you are likely to notice first, and when

Appetite change tends to arrive before weight change. Many people find that within the first one to two weeks at even the 0.25mg starting dose, meals feel more filling, the impulse to snack is quieter, and the pull of food between meals softens noticeably. This is not the same as dramatic weight loss, it is semaglutide beginning to act on the GLP-1 receptors involved in appetite regulation and gastric emptying. The scales may not move much yet. That is expected.

By weeks four to eight, with dose escalation underway, modest weight reduction usually becomes visible. A kilogram or two is realistic for this phase, depending on individual factors including starting weight, diet and activity. This is also the window when gastrointestinal side effects (nausea, loose stools, indigestion) are most commonly reported, typically after a dose increase and settling within days to a couple of weeks. The NHS medicines page for semaglutide covers what to expect and when to seek help.

The months from roughly week 16 onward, once you are on the full maintenance dose, tend to produce the most consistent progress. Appetite suppression is more sustained, energy from food is used differently, and cumulative weight loss accelerates. If you have been wondering how long until Wegovy kicks in and whether slow early progress means the medicine is not working, the answer most of the time is simply that the escalation phase is doing its job. Patience through the titration period pays off.

What affects how quickly Wegovy works for you personally

Trial averages describe populations, not individuals. Several factors shape how quickly any one person responds. Starting BMI plays a role, people with higher starting weights may see larger absolute losses in the early months even if the percentage change is similar. Metabolic health, physical activity and dietary habits all interact with the medicine. Sleep quality and stress levels influence weight regulation too, in ways that no injection can entirely override.

The dose escalation timeline itself is a variable. Some people tolerate the steps smoothly and reach 2.4mg on the standard schedule; others need an extra month at a given dose to settle gastrointestinal symptoms. Both are clinically acceptable. Rushing the titration to see faster results is not advisable, and a prescriber will not do it. If you are curious about how Wegovy compares in timeline to the broader category of semaglutide medicines, the semaglutide timeline page covers that territory. For a look at costs alongside your treatment options, the Wegovy pricing page sets out what private treatment typically involves.

One practical thing worth noting: keeping your pen refrigerated and injecting on the same day each week (many people tie it to a recurring evening, much like a standing reminder on the phone) helps maintain steady drug levels and makes any week-on-week changes easier to track. The guide to your first day on Wegovy covers the detail of starting out.

When to speak to your prescriber about slow progress

Most of what feels like slow progress in the first eight weeks is normal. The medicine is doing quiet work before the weight loss becomes obvious. That said, there are times when a conversation with your prescriber is the right call. If you are experiencing side effects severe enough to affect daily life, or if you have reached the maintenance dose and seen very little change after several months, those are both worth raising directly.

The 5% threshold after six months on maintenance dose is the clinical benchmark used in NICE guidance. It is not a judgment, it is a practical assessment of whether the medicine is the right tool for you. Wegovy is a prescription-only medicine reviewed by a clinician before every repeat; that ongoing clinical oversight exists precisely for moments like this. For an overview of the full range of weight-loss treatment options and how the consultation works, that page sets out what to expect. You can also read more about how long Wegovy takes to work in contexts where the dose journey is the main question, or explore the broader Wegovy treatment overview if you are still in the research stage.